Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

Tablets: SOP for Inspection of Granule Flow Properties During Compression – V 2.0

Posted on By

Tablets: SOP for Inspection of Granule Flow Properties During Compression – V 2.0

Standard Operating Procedure for Inspection of Granule Flow Properties During Compression

Department Quality Control
SOP No. SOP/TAB/131/2025
Supersedes SOP/TAB/131/2022
Page No. Page 1 of 6
Issue Date 01/03/2026
Effective Date 06/03/2026
Review Date 01/03/2027

1. Purpose

To define the procedure for inspecting the flow properties of granules during the compression process to ensure uniform and efficient tablet formation.

2. Scope

This SOP applies to the inspection of granule flow properties during tablet compression. It ensures that granules have appropriate flow characteristics for consistent tablet compression and quality.

3. Responsibilities

  • Quality Control (QC): Responsible for inspecting granule flow properties and ensuring that they meet the required specifications for uniform tablet compression.
  • Compression Operator: Responsible for adjusting machine parameters to ensure that the granules flow properly during the compression process.
  • Quality Assurance (QA): Ensures that the granule flow inspection procedure is followed according to this SOP and reviews results for compliance with quality standards.

4. Accountability

The QC Manager is accountable for ensuring that the granule flow properties are inspected accurately during the compression process. The QA Manager is responsible for reviewing and ensuring compliance with the inspection results.

See also  Tablets: SOP for Adhesion Testing of Enteric Coating During Coating - V 2.0

5. Procedure

5.1 Granule Flow Property Assessment

  1. Inspect the granules before and during the compression process to evaluate their flowability, which is crucial for consistent tablet formation.
  2. Granules should be free-flowing without clumping, bridging, or poor flow, which could cause irregular tablet weight or formation issues.

5.2 Flow Property Testing Methods

  1. Perform a flowability test using methods such as the “angle of repose” test, “Hausner ratio,” or “Carr index” to evaluate the granule’s flow characteristics.
  2. For the angle of repose test:
    • Place the granules in a funnel and allow them to flow freely onto a flat surface.
    • Measure the angle formed between the surface of the pile and the horizontal plane. A typical acceptable angle of repose range for granules is 25°–35°.
  3. For Hausner ratio or Carr index:
    • Calculate the bulk and tapped density of the granules to assess flowability. The Hausner ratio should ideally be between 1.2 and 1.5 for good flow.
    • The Carr index should ideally be below 15% for good flow.

5.3 Sample Collection

  1. Collect representative samples of granules at regular intervals during the granulation process, typically every 100 grams of granules produced or after each major granulation stage.
  2. Ensure that the sample is representative of the entire batch by collecting from different locations (top, middle, and bottom of the batch).
See also  Tablets: SOP for Process Troubleshooting in Tablet Manufacturing - V 2.0

5.4 Monitoring and Adjustments

  1. Monitor the flow properties during the compression process. If any issues, such as poor flow or clogging, are detected, adjust the compression machine settings or the granulation process.
  2. For poor flow, consider adjusting the granule size distribution, moisture content, or binder levels in the granulation process.
  3. If issues persist, perform additional granulation to optimize flow properties.

5.5 Documentation

  1. Record all granule flow property results, including test methods, values, and any corrective actions taken, in the batch record (Annexure-2).
  2. Document any deviations or corrective actions in the deviation report (Annexure-1).
  3. Ensure that all records are signed, dated, and reviewed by QA for compliance.

5.6 Acceptance Criteria

  1. Granules should exhibit good flowability with an angle of repose between 25° and 35° and a Hausner ratio between 1.2 and 1.5.
  2. If the flow properties fall outside the specified range, corrective actions should be taken, such as modifying the granulation parameters or reprocessing the granules.

5.7 Post-Compression Actions

  1. Once the granule flow properties are acceptable, proceed with the compression process and continue to monitor flow properties as needed during subsequent batches.
  2. Ensure that all monitoring equipment is cleaned and calibrated as required after each inspection.
See also  Tablets: SOP for Troubleshooting Capping and Lamination Issues in Tablets - V 2.0

6. Abbreviations

  • SOP: Standard Operating Procedure
  • GMP: Good Manufacturing Practice
  • QC: Quality Control
  • QA: Quality Assurance
  • API: Active Pharmaceutical Ingredient

7. Documents

  1. Batch Record (Annexure-2)
  2. Deviation Report (Annexure-1)

8. References

  • USP <1174> – Powder Flowability Testing
  • 21 CFR Part 211 – Current Good Manufacturing Practice for Finished Pharmaceuticals (US FDA)
  • European Pharmacopoeia (EP) – Granule Flow Properties

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Deviation Report

Deviation Date Batch Number Deviation Description Corrective Action Responsible Person
15/12/2025 Batch 001 Poor granule flow resulting in uneven tablet weight Adjusted granule binder content and compression settings Jane Doe

Annexure-2: Batch Record

Sample Number Flow Property Test Result Action Taken
Sample 1 Good flowability (Hausner ratio 1.3) Accepted

Revision History:

Revision Date Revision No. Revision Details Reason for Revision Approved By
01/01/2024 1.0 Initial Version New SOP Creation QA Head
01/02/2025 2.0 Updated flow testing methodology Improved testing procedure QA Head
Tablet Manufacturing V2.0 Tags:GMP tablet manufacturing SOP, SOP for tablet production, SOP for tablet quality control, SOP tablet inspection process, SOP tablet packing and sealing, Tablet batch record review, Tablet blending SOP, Tablet cleaning and maintenance, Tablet coating procedure, Tablet compression SOP, Tablet disintegration test procedure, Tablet dissolution procedure, Tablet formulation SOP, Tablet friability testing SOP, Tablet labeling and packaging SOP, Tablet manufacturing equipment SOP, Tablet manufacturing SOP, Tablet manufacturing SOPs, Tablet packaging SOP, Tablet production procedure, Tablet quality assurance SOP, Tablet quality control SOP, Tablet sampling and in-process testing SOP, Tablet stability testing SOP, Tablet storage and handling procedure, Tablet uniformity testing procedure, Tablet weight variation SOP

Post navigation

Previous Post: SOP for Storage of Hygroscopic Raw Materials with Desiccants – V 2.0
Next Post: Capsule: SOP for Regulatory Compliance During Product Development – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version